Sung-Bum La

Title: Innovations of Sung-Bum La in Drug Delivery Systems

Introduction

Sung-Bum La is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly focusing on colon-selective compositions. His innovative approach aims to enhance the effectiveness of drug delivery to the colon, which is crucial for treating various gastrointestinal conditions.

Latest Patents

Sung-Bum La holds a patent for a colon-selective drug delivery composition. This composition comprises gelatin and a polysaccharide that is degradable by colonic enzymes. Additionally, it may include an aldehyde, a polyvalent metal ion, or an additional polysaccharide that remains intact in the upper gastrointestinal tract. This innovative formulation allows for the selective delivery of active substances to the colon, ensuring effective release where it is most needed.

Career Highlights

Sung-Bum La is associated with Samyang Corporation, where he continues to develop and refine his innovative drug delivery technologies. His work has the potential to significantly impact the pharmaceutical industry by improving therapeutic outcomes for patients requiring targeted treatments.

Collaborations

He collaborates with esteemed colleagues, including Seung-Seo Lee and Chang-Baeg Lim, who contribute to the advancement of research and development in this field.

Conclusion

Sung-Bum La's contributions to drug delivery systems exemplify the importance of innovation in healthcare. His patented work on colon-selective drug delivery compositions represents a significant advancement in the field, promising improved treatment options for patients.